Signalling pathways in succinate dehydrogenase B-associated renal carcinoma

Stewart Fleming (Lead / Corresponding author), Nick J. Mayer, Ljiljana J. Vlatkovic, Joanne McLean, Michelle McConachie, David Baty

    Research output: Contribution to journalArticlepeer-review

    8 Citations (Scopus)



    Renal tumours have recently been described in association with mutations in the gene encoding the B subunit of succinate dehydrogenase, a mitochondrial Krebs cycle and electron transport chain enzyme (SDHB-associated renal cell carcinomas). The aim of this study was to investigate the roles of different signalling pathways in the pathogenesis of these tumours.
    Methods and results

    We used immunohistochemistry and antibodies against phospho-specific epitopes to examine the activity of three potential signalling pathways in tumour cells of three genetically confirmed cases of SDHB-associated renal cell carcinomas. We found no evidence supporting a role for either the mTOR [p-mTOR (Ser2448), p-S6 riboprotein (Ser235/236)] or hypoxia-inducible (carbonic anhydrase 9 and EGFR) pathways. However, there was immunohistochemical reactivity for phosphorylated AMP-dependent kinase (p-AMPK Thr172) and glycogen synthase kinase 3 (GSK3) phosphorylation (p-GSK3 Ser12), and nuclear expression of cyclin D1.

    We suggest that these tumours may arise through a mechanism involving ATP depletion, activation of AMPK, and induction of cyclin D1, and that this may be a unique pathway of tumour development that has the potential for therapeutic intervention in these rare tumours.
    Original languageEnglish
    Pages (from-to)477-483
    Number of pages7
    Issue number4
    Publication statusPublished - Mar 2014


    • AMP-Activated Protein Kinases
    • Adult
    • Aged
    • Carcinoma, Renal Cell
    • Cyclin D1
    • Female
    • Germ-Line Mutation
    • Glycogen Synthase Kinase 3
    • Humans
    • Immunohistochemistry
    • Kidney Neoplasms
    • Middle Aged
    • Phosphorylation
    • Signal Transduction
    • Succinate Dehydrogenase
    • TOR Serine-Threonine Kinases


    Dive into the research topics of 'Signalling pathways in succinate dehydrogenase B-associated renal carcinoma'. Together they form a unique fingerprint.

    Cite this